This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Products from multiple soldto's are in cart. Only products from single soldto is allowed in cart.
No Items In Cart
West is committed to the safe and efficient delivery of drug products to patients. Key to this is not only staying abreast of industry developments, but also being prepared to help customers address them. This is a focus of the Integrated Solutions platform.
For example, Dow Corning recently introduced a new product – Dow Corning® 366 35% Dimethicone NF Emulsion – an update of their 365 product. The difference between 365 and 366 is that the 366 product does not use a surfactant listed on the European Chemicals Agency REACh (Registration, Evaluation, Authorisation and Restriction of Chemicals) Authorisation List. These silicone-based products are used widely in the lubrication of glass syringes.
Switching to 366 presents a challenge of having to qualify new products; West is well-positioned to assist those customers facing this challenge through offerings that include filling syringes, evaluation of essential performance requirements (e.g., break loose and glide force, delivery volume, container closure integrity), identification of any incompatibility (e.g., drug product interaction with silicone product that alters syringe function or results in particulate formation), and evaluation of targeted leachables.
West has the staff, expertise and facility to design and execute the experiments needed to help reduce customer risk. For more information, contact an Account Manager, or Technical Customer Support (TCS) representative.
Simplify the Journey™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Dow Corning® is a registered trademark of Dow Corning Corporation.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.
According to Health Resources & Services Administration (HRSA), in the US about 110,000 people are waiting for organs right now and about 20 patients die each day waiting for a transplant<sup>1</sup>. Due to shortage of donors and requirements for matching, there is a huge demand for manufactured tissues and organs. Bioprinting has emerged as a very promising tool for solving this major unmet need in healthcare.
It’s been more than four years since the halls of West’s headquarters saw its first four-legged visitor, the sweet and lovable Canine Partners for Life puppy-in-training Dookie. Since then, Friend, Star, Cret, Journey, Digger, Muzzy and a host of others have filled the halls with warm brown eyes and wagging tails.
<p><em>Dr. Heike Kofler, Amy Miller, Jennifer Riter<br /></em><em>West Pharmaceutical Services, Inc.</em></p><p>One of the critical success factors for packaging lyophilized drugs is protection against product degradation caused by moisture. Moisture can be introduced into a lyophilized drug product cake from the elastomeric stopper and from the atmospheric headspace; it can also permeate through the stopper, a process known as moisture transmission.</p>
<span style="color: #000000;">In a recent Flash Report, Rx-360.org offered a summary of the proposed USP Chapter 1083 – Good Distribution Practices – Supply Chain Integrity. In its report, Rx-360 noted that “globalization of all aspects of the pharmaceutical business has driven the need to address the threats of counterfeit or adulterated medication, devices and components, for which there have been several high-profile examples over the last few years.”</span>
Summer interns from West’s Exton, PA headquarters recently participated in a volunteer day at the newly renovated Canine Partners for Life facility in Cochranville, Pennsylvania. <br />